EnergyRenewable Energy
Helius Energy

Non-exec ups stake in Helius Energy


Directors have continued their recent buying into biomass plant builder Helius Energy (LON:HEGY) with new non–executive Alastair Salvesen snapping up more shares.

Salvesen, a leading figure in the UK’s seafood industry who has directorships in a number of businesses, now owns 23.01 per cent of the cleantech firm, up from 22.39 per cent.

Salvesen, who through his family’s holding also retains a major shareholding in Aggreko (LON:AGK), the quoted Glasgow plant hire group, was appointed to the board last week 

New chief operating officer, William Ingram Hill, 35, also bought recently 250,000 shares in the company for 11.5p each.

Helius is developing biomass-fired renewable electricity  generation plants at sizes ranging from around seven megawatts to 100MW.

The firm is involved in several projects and its long-term aim is to be an owner/operator of 500MW worth of power plant assets.

The group is focused on a 100MW Avonmouth biomass plant, located on the Bristol Channel; a 7.2MW project in Scotland with the Combination of Rothes Distillers (CoRDe); and another 100MW biomass plant proposed for Southampton.

Helius also developed the 65MW net capacity Stallingborough biomass plant, located on the south side of the Humber estuary in Lincolnshire.

Helius Alpha, a subsidiary that owned the rights to develop and operate the plant, was then sold in its entirety to RWE Innogy.

In early October, Helius raised £6.6 million in a placing priced at 16p pence per share.

Quick facts: Helius Energy

Price: £0.00

Market: AIM
Market Cap: £0.00

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: CB2 Insights licenses electronic data capture software to UK...

CB2 Insights (CSE:CBII-OTCQB: CBIIF) CEO Prad Sekar joined Steve Darling from Proactive Vancouver to discuss the company doing a deal with MYACCESS Clinics. This will allow CB2’s software to capture comprehensive data sets related to patient health and treatment histories and manage ongoing...

2 days, 10 hours ago

2 min read